Introduction make synthetic peptides corresponding to these sequences as potential therapeutic reagents [4, 5] . We A basic understanding of the cellular and molecular first showed that peptides corresponding to specific mechanisms of organ transplant rejection may provide HLA sequences could block cytotoxic T lymphocytes new insights into the mechanism of action of existing (CTL) in an allele-specific manner. Synthetic peptides drugs and lay the foundation for the development of corresponding to residues 98-113 of HLA-A2 spenovel approaches to immunotherapy. We have focused cifically inhibited cytolysis directed at HLA-A2, but on the T lymphocyte as a mediator of transplant not other HLA types [4] . We proceeded to define a rejection. T cells recognize foreign HLA on the graft series of synthetic peptides corresponding to linear and orchestrate various eÂector arms involved in both sequences of HLA molecules that blocked a variety of humoral and cellular immunity [1 ] . We designed synassays both in vitro and in vivo [5] [6] [7] . The most thetic peptides corresponding to structural regions of interesting of these peptides corresponded to the a1 HLA molecules and used them to modulate the alpha helix of HLA class I molecules ( Figure 1 ) . A immune response. Over the past decade the use of such subgroup of these peptides, corresponding to residues peptides has progressed from the bench to the bedside 60-84 of HLA-Bw4a, inhibited cytotoxicity between [2 ] . This report will briefly summarize this progress.
all donor-recipient pairs in vitro. Furthermore these human sequences induced immunological tolerance in animal models of transplantation ( Figure 3 ) [8] . Based
The role of HLA in the alloresponse upon these studies, SangStat Medical Corporation, Menlo Park, CA, USA, licensed the peptide technology The human leukocyte-associated (HLA) antigens and developed it under the brandname 'Allotrap@'. In encoded in the major histocompatibility complex collaboration with Jean-Paul Soulillou and colleagues, ( MHC) on chromosome 6 in man subserve numerous SangStat showed that the Allotrap@ peptide was nonfunctions in the immune response, but they were first toxic in phase I clinical trials and embarked upon identified as molecules that direct and restrict transphase II trials in France. Recent results from this plant rejection [3 ] . Studies of the structure of HLA group show that the peptides inhibit natural killing (a class I ( Figure 1 ) and definition of the structure and surrogate marker for CTL and cell-mediated immune function of the T cell receptor provided new insights responses) in vivo in patients who have received otherinto the mechanism of HLA recognition, T cell activawise standard therapy for renal transplantation [9 ] . tion, and diÂerentiation, and the events leading to
The mechanism of action of these peptides is still acute and subacute transplant rejection [1 ] . Non-self unclear. Of interest, however, the functional peptides, HLA molecules are recognized by T cell receptors by like the immunosuppressive drug deoxyspergualin, both 'direct' and 'indirect' pathways. In the direct bind to members of the heat shock protein 70 family pathway, whole foreign HLA is recognized, while in of chaperones [7 ] . In addition, these peptides correthe indirect pathway, non-self HLA peptides are spond to regions of HLA class I molecules recognized recognized in the context of self HLA ( Figure 2) .
by natural killer inhibitory receptors, KIR. These receptors send inhibitory signals into natural killer cells when they recognize HLA molecules on target HLA class-I-derived peptides cells [10 ] .
In 1985 we reasoned that linear sequences of HLA molecules may be important in the interaction between HLA class-II-derived peptides regions of mhC class II molecules had similar inhibitory eÂects both in vitro and in vivo [11] . They interpreted their findings in the context of competition for target antigens in 'indirect allorecognition'. Recently we described a sequence corresponding to a relatively monomorphic region of an HLA class II molecule that inhibits T cell proliferation by blocking cell-cycle progression. This peptide, derived from the a1 alpha helix of HLA-DQ 03011, inhibits proliferation of human peripheral blood lymphocytes, purified T cells, and cytolysis by CTL in an allele non-specific, doseresponsive manner. Proliferation to interleukin-2 (IL-2) was blocked, but signalling through the IL-2 receptor was intact. S6 kinase activity, downstream of the IL-2 receptor, is inhibited. Like rapamycin [12 ] , this peptide inhibits cdk2 kinase activity by blocking degradation of the p27 cell cycle inhibitor. However, unlike rapamycin, the DQ peptide is unable to inhibit yeast cell growth. Thus a peptide from the same region of an HLA class II molecule as previously described . Survival of rat heterotopic heart allografts. LEW donor hearts were transplanted into the abdomen of ACI recipients and palpated daily. Rejection coincides with a loss of heart beat. Either (a) intravenous injection or ( b) gavage of synthetic peptide B7 (corresponding to residues 75-87 of HLA-B7), with a 5-day course of oral cyclosporin, resulted in long-term graft survival. ( Reprinted with permission from Krensky AM, Clayberger C. The induction of tolerance to alloantigens using HLA-based synthetic peptides. Curr Opin Immunol 1994; 6: 791-796.)
for class I molecules also has functional eÂects on T peptides are currently being evaluated in clinical trials. lymphocytes, but the two sets of peptides function via In animal models these peptides, given over 1 week entirely diÂerent mechanisms. with cyclosporin alone, induced long-term immunological tolerance ( Figure 3 ). They may similarly induce tolerance in humans. The next major hurdle for such
Summary and conclusions
tolerogenic drugs, however, is to prove eÃcacy in clinical circumstances. Many of the drugs used to treat transplant patients today (steroids, cyclosporin, azaOver the past decade the use of synthetic peptides thioprine, mycophenolate mofetil ) may actually inhibit corresponding to linear sequences of HLA molecules has progressed from a concept to a reality. These the 'active' processes of induction and maintenance of GK, Krensky AM. HLA-A2 peptides can regulate cytolysis by immunological tolerance. Demonstration that new human allogeneic T lymphocytes. Nature 1987; 330: [763] [764] [765] drugs induce tolerance will require eÃcacy studies in 6. Clayberger C, Lyu S-C, DeKruyÂ R, Parham P, Krensky AM.
other immune-mediated diseases in which monother- and diastolic pressure are calculated from measured both age and height [10 ] . However, these Tables are rather diÃcult to handle in daily practice. mean arterial pressure in a suÃciently accurate manner. In very-low-birth-weight neonates larger cuÂs are more appropriate, but hypotension cannot adequately be [11 ] . for the evaluation of arterial hypertension in adults as Compared to reference values obtained from casual well as in children and adolescents [5] . In the paediatric blood pressure measurements [1, 8] mean systolic dayage group nearly exclusively oscillometric ambulatory time ambulatory blood pressure rose only moderately blood pressure monitors are in use. Whereas blood by height, from 112 to 124 mmHg in boys and from pressure can be measured accurately in mildly active 111 to 120 mmHg in girls, whereas mean diastolic or inactive children, no reliable measurements are daytime blood pressure was 72-74 mmHg, irrespective obtained during exercise and vigorous physical activity of height or sex. Small children had systolic as well as [6 ] . Systolic and diastolic blood pressure follow a diastolic daytime ambulatory blood pressure means typical circadian rhythm, values being 15-25% lower significantly above normal casual blood pressure at at night than during the day.
rest, whereas this eÂect was less pronounced in taller adolescents. The reason for this discrepancy cannot be explained on a biological basis (e.g. higher level of physical activity throughout the day in younger chil-
What blood pressure is normal in children?
dren). Particularly, lack of rise in diastolic blood pressure during maturation does not correspond to the A number of epidemiological studies have established findings of casual measurements in a variety of epidenormal blood pressure values in diÂerent populations. miological studies. Methodological diÃculties (e.g. Labarthe [7 ] reviewed 88 epidemiological reports on algorithm constructed for adults) might explain this blood pressure in children from 30 countries: a consist-phenomenon. There was a large decrease of blood ent increase in both systolic and diastolic blood pres-pressure during the night by more than 20% of daytime sure with age was observed in almost all surveys. A pressure. marked increase in average blood pressure with age in childhood and adolescence may be one aspect of
The diagnosis of hypertension in children normal growth and development. Distribution and percentiles of general populations provide references for blood pressure in growing children: there is a Criteria for the diagnosis of hypertension in adults are not applicable to children. A value of 140/90 mmHg progressive rise of casual blood pressure of approximately 1.5 mmHg systolic and 0.7 mmHg diastolic per for casual blood pressure and 135/85 mmHg for daytime ambulatory blood pressure is generally accepted year of age.
Combined data from several studies as references as the upper limit of normal blood pressure in adults, and this might also be true for adolescents. Since a for casual blood pressure has been published from studies performed in the United States [1 ] and in linear relationship exists between height and blood pressure and between log weight and blood pressure, Europe [8] . The United States data included one European study, the Brompton study of more than a major blood pressure determinant in childhood is body size. Therefore it has been recommended that 7000 children aged from 4 days to 5 years [9 ] . Although the Task Force stresses the importance of making blood pressure levels in the growing child should be related to height. several blood pressure recordings in any individual child before drawing conclusions about the blood Uncertainties exist with regard to normal blood pressure range, and there is no agreement on the exact pressure, only the first blood pressure readings made in the 70 000 subjects were used to prepare its stand-definition of hypertension at diÂerent ages. The most helpful criterion for the definition of hypertension in ards, because in one of the nine studies just one blood pressure measurement per subject was available. In an children is the persistence of blood pressure above the 95th percentile. With repeated measurements not 5% attempt to incorporate the important contribution of body size into the analysis, the Task Force has added (95th percentile), but even less (about 1%) of the children show chronic high blood pressure. When the 90th percentile of height and weight for normal children at the bottom of the charts. The European ambulatory blood pressure values with oscillometric devices are the basis to diagnose arterial hypertension, percentile charts have related casual blood pressure to height rather than to age. Recently, tables for blood separate reference values should be used [11] ( Table 1 ) . pressure in children were published taken into account patients had required daily or alternate day haemodia-Does renal replacement therapy aÂect the residual lysis, and many dialysis treatments were complicated renal function in acute renal failure?
by transient blood pressure reduction to mean values as low as 70-90 mmHg, despite an overall stable We have studied the eÂects of intermittent haemodialysis clinical condition. The temporary decline of the blood (IHD) and continuous haemodialysis (CVVHD) on the pressure, which was within the autoregulatory range residual kidney function in critically ill patients with of the healthy kidney, seemed to be the only explana-acute renal failure [7] . The data has been published tion for the presence of these new ischaemic lesions. only in abstract form. Twenty-seven patients were Solez compared renal biopsies in 50 patients with treated with intermittent haemodialysis and 16 patients persistent acute renal failure with biopsies from seven with continuous haemodialysis using polysulphone patients who had recently recovered from ARF [3] . membranes in each group. Creatinine clearance, urea The biopsies were taken 3-4 weeks after the onset of clearance, urine volume, and fractional excretion rate renal failure, at a time when regeneration of the for sodium were measured for 3 h before dialysis, during damaged tubular epithelium should have been com-dialysis and for 3 h after intermittent haemodialysis. pleted. Morphological analysis of the biopsies showed The same parameters were determined for 3 h before, necrosis of the tubular epithelial cells and loss of the 0-3 h and 4-6 h during continuous haemodialysis. PAS-positive brush border in the proximal tubules, Virtually all renal function parameters changed sigwhich were significantly more severe in the ARF group nificantly during and after intermittent haemodialysis, than in the recovery group. Both of these histological indicating an acute worsening of residual kidney funcchanges could contribute to renal function failure in tion. Creatinine clearance, which represents an estima-ARF by permitting passive backflow of tubular filtrate tion of the glomerular filtration rate (GFR), declined and by causing decreased tubular reabsorption of significantly intra-and postdialysis, when compared to sodium, resulting in stimulation of renin release and predialysis (Table 1 ) . However, as GFR falls, enhanced aÂerent arteriolar vasoconstriction [3] . Tubular casts tubular creatinine secretion leads to an up to twofold seemed to play no role in the maintenance of renal overestimation of GFR by the creatinine clearance. failure. The data suggests that necrosis of tubular The variability of tubular urea reabsorption, which epithelial cells is a continuing process, not necessarily depends on the degree of sodium and water reabsorplimited to the original lesion, and contributing to, if tion, causes urea clearance to underestimate GRF by not causing, continued renal failure and prolonged 30-50%. The mean of creatinine clearance and urea ATN. These observations may be explained by the clearance, which may be a closer estimation of true results of the animal experiments, described below. glomerular filtration rate in patients with moderate to advanced renal insuÃciency [8 ] , was also substantially
The post-ischaemic kidney in acute renal failure lower during and after dialysis compared to predialysis. However, if serum creatinine falls during dialysis below Animal experiments designed to evaluate possible rela-the saturation limit of the secretory mechanism, tionships between alterations in renal haemodynamics changes in creatinine clearance after dialysis may not and ongoing damage of the surviving or recovering necessarily reflect changes in GFR. In this case, the nephrons showed an impaired ability to autoregulate declining serum creatinine during dialysis would cause renal blood flow in post-ischaemic ARF. decreased tubular creatinine secretion, which in turn Haemorrhagic reduction in renal perfusion pressure would falsely suggest a decreased GFR. Two studies within the autoregulatory range was associated with investigated the eÂects of dialysis on creatinine secreparadoxical vasoconstriction (rather than vasodilat-tion in chronic renal failure and the importance of ation), leading to a substantial decrease in renal blood creatinine clearance as an estimate of GFR in ARF. flow, further reduction in creatinine clearance and The first study showed an increased creatinine secretion histological evidence of recurrent ischemic injury [4] . It was shown that the post-ischaemic kidney exhibits [9 ] . The the first 6 h of CVVHD in comparison to IHD and further comparisons using comparable dialysis preauthors propose the hypothesis that dialysis eliminates scriptions in regard to urea clearance, solute removal substances which inhibit tubular creatinine secretion. and volume removal are necessary to confirm this The second study reports a good correlation between advantage. Further research should also focus on the creatinine clearance and inulin clearance in ARF (r= question of whether dialysis-induced hypoperfusion is 0.93) [14] . We believe therefore that the observed limited to the kidney or whether it also aÂects other significant decline in creatinine clearance and urea organ systems adversely. Our study was not designed clearance during and following intermittent haemodiato investigate possible diÂerences between both treatlysis suggests a marked decrease of the glomerular ment modalities in terms of mortality. The fact that filtration rate.
CVVHD is associated with less change in residual There are several explanations for these observarenal function does not necessarily translate into tions. First, the MAP fell during IHD by 7% from a improved morbidity or mortality. baseline of 84 mmHg. The correlation between the percentage decrease in creatinine clearance and the fall in MAP during dialysis (r=0.72, P<0.001) provides References evidence that renal hypoperfusion during and following reabsorption ( Table 1 ) [11, 12] . In our study of ARF renal function [15, 16] . . Nevertheless, multiple studies have drawn diÂerent conclusions based upon the period issues because an expensive treatment is being oÂered to a population with limited life-expectancy, and of evaluation, type of patient, and study design. An early study [4 ] of 157 patients with a mean age of 75 socioeconomic because of the progressive increase in the proportion of elderly requiring ESRD therapy years and multiple comorbidities at initiation of dialysis (17.2% of patients had diabetes, 35% had coronary worldwide [1 ] . According to the US Renal Data System ( RDS), 1995 Annual Data Report, the median disease, 10% had cerebrovascular disease, 18% had chronic obstructive pulmonary disease, and 22% periage at incidence of ESRD has reached 62-63 years in the US, Japan, Germany, France and Italy [2 ] . Indeed, pheral vascular disease) found 3-and 5-year survival rates of 47% and 22%, respectively. Despite these geriatric ESRD will be an important topic for 21st Century physicians to face. In the U.S., it is projected comorbidities, most of the patients were doing well, had social contacts (90%), spent time outdoors (86%) that 60% of the ESRD population will be over 65 years in the year 2000.
and ranked high on Karnovsky scale (73% of patients with scale >80%). In addition, 40% perceived their health to be better than 70-year old subjects, while
Factors to be considered in oÂering renal only 25% regarded their health as worse. An acceptable replacement therapy to elderly patients with ESRD subjective quality of life and degree of rehabilitation have also been noted in other reports [4] [5] [6] [7] [8] . In the When making decisions about initiating, withholding, Battelle Human AÂairs Research Center Study [8 ] of or terminating dialysis in the elderly or the appro-859 dialysis and transplant patients, 70% of the elderly priateness of oÂering renal transplantation to these dialysis patients (comprising 16% of the total numbers individuals, several important points must be consid-of the elderly dialysis) fell in the top four categories of ered: (1) The elderly are a 'heterogeneous' group of overall functional status using the Karnovsky index. persons united by 'chronologic', but not necessarily It has been proposed that the regular visit to the 'biologic', age (physiologic, psychologic, or social func-dialysis unit and mixing with younger patients may act tioning). The latter (biologic age) has a variable expres-as a beneficial social stimulus in elderly patients [6 ] . sion depending on the pace of ageing as well as the However, the importance of this social eÂect is brought impact of comorbid pathologic conditions whose into question by the observation in one study that number and severity increases with age. (2 ) When those elderly subjects treated by home HD had the analysing results of renal replacement therapy (RRT ) highest quality of life, as assessed by life satisfaction, in the elderly, health care professionals must recognize well-being index, and psychological aÂect [9 ] . the importance of not only 'absolute' survival time of these individuals, but also the 'quality' of that survival. Factors impacting on quality of life Stated otherwise, the goals of RRT in the elderly is to add 'life to years', not simply 'years to life'. Two more recent studies painted a much grimmer Furthermore, while there might be little disagreement picture of the life of elderly dialysis patients [10, 11] , on the definition of quality of life, the yardstick for its especially when ESRD is caused by diabetes. It is measurement has not been straightforward. ( 3) When important, however, to appreciate the flaws in the renal transplantation is being considered for the elddesign of these studies. These include basing the data erly, a dilemma exists if it is 'fair' to waste an invaluable on recollection in one study, not realizing the full resource (the cadaver kidney) to an elderly individual benefits of erythropoietin, and not addressing dialysis with a limited life-expectancy. i.e. send a functioning adequacy. In addition, the conclusions may not apply graft to the grave with the elderly.
to patients who do not live in the inner city. These studies, however, demonstrate the impact that poverty,
Survival of the elderly on dialysis
illiteracy, and other urban troubles can have on the likelihood of rehabilitation. Therefore, negative results such as these should not provide ammunition for those Despite complex comorbid and psychosocial conditions, survival and the quality of life in the elderly who wish to institute age-based rationing of HD, but rather, among other things, to examine the critical morbidity and mortality are limited, however, by small sample size or the possibility of selection bias among issue of rehabilitation and most importantly early implementation of measures that might improve func-CAPD patients. tional status whenever it is significantly impaired.
A recent study suggested that racial diÂerences may Transplantation in the elderly-an under utilized aÂect the outcome of elderly dialysis patients [12 ] .
opportunity?
Black elderly patients were found to have higher survival rates (57 vs 38% at 3 years) and a better quality of life than white patients. The following factors may Over the last decade, the eÃcacy and safety of renal transplantation in the elderly has been demonstrated have contributed to these diÂerences: (1) blacks spent more time on dialysis per week than whites, (2 ) whites in several published reports [22] [23] [24] [25] [26] . One-year patient survival now ranges between 80-90% and 5-year had more dialysis-accelerated atherosclerosis, cardiovascular morbidity, and other comorbid conditions at patient survival for cadaveric renal transplantation (CRT ) has increased to 70%. 'Functional' graft sur-3 years and (3 ) blacks may be more likely to die of 'competing risks' before reaching kidney failure; as a vival has increased in parallel, averaging 80% at one year and 55-60% at 5 years. The increasing success of result, those who survive to chronic dialysis may constitute a 'hardier group'.
organ transplantation in the elderly, coupled with a chronic persistent shortage in cadaver donors have In the aggregate, therefore, prolonged survival in the elderly on HD is feasible. Furthermore, the elderly created an ethical dilemma for physicians regarding the allocation of a scarce resource (the cadaver kidney) can adapt to a complicated treatment regimen and activities, and may be more compliant than younger to the elderly with limited-life expectancy.
Ageing is accompanied by senescence of the immune patients [13 ] . However, malnutrition and the potential for under dialysis, as well as depression and withdrawal system [27 ]. The T-lymphocyte population undergoes major alterations with age resulting in a decline in cellfrom dialysis are serious complications in the elderly dialysis patient [14 ] . mediated cytotoxicity. T-cells of elderly do not recognize self-MHC. These changes lead to down regulation of the T-cell activation cascade, with less rejection Dialysis technique and the elderly episodes to organ transplantation. On the other hand, these changes also lead to a decline in cell-mediated immunity against viral, bacterial, and fungal infections. The new synthetic membranes and the full benefits of erythropoietin hopefully will decrease the incidence of B-cell function is unimpaired in the elderly; however, reduced antibody response to foreign antigens declines these complications in the elderly dialysis patient. Most importantly, delivery of 'adequate' dose of dialysis because of impaired CD 4 + helper function. This tradeoÂ (decreased rejection and increased vulnerability ( KT/V>1.4 ) is critical to the elderly. Five-and 10-year survival rates of 69% and 64%, respectively, were to infection) necessitates modification of immunosuppressive therapy in the elderly. achieved in patients older than 64 years in one of the longest studies of high dialysis doses ( KT/V=1.67)
Patient death with a functioning allograft accounts for the majority of graft loss in older transplant reported from France by Laurent et al. [15] .
Similarly, the outcome of chronic peritoneal dialysis patients [22] [23] [24] [25] [26] . In several studies, older patients had a graft loss rate of nearly 50% as a consequence of (CPD) in the elderly is also acceptable, with 5-year survival rates of 20-30% [3, [16] [17] [18] [19] . CPD is thus an death compared to a rate of 15% in younger patients.
Since graft loss in the elderly is related primarily to alternate dialysis modality for the elderly and may confer some advantages such as absence for vascular patient death (and not immunologic graft-loss), and the two main causes of mortality following transplantaaccess and the promotion of independence and a sense of self-worth. Also the judicious use of CPD in nursing tion are cardiovascular disease and infection, it follows that comprehensive preoperative evaluation of elderly homes, the use of home helpers, and the development of Adult Health Care Centers may enable physicians patients is imperative to improve patient and thus graft survival. Similarly, the goal of immunosuppression to oÂer this modality to more elderly patients. Although many comparisons have been made of mor-protocols in the elderly should be to reduce the risk of infection without causing rejection and consequent tality between HD and CAPD for the ESRD population as a whole, only few specific studies have addressed high-dose immunosuppression, infection, and graft loss. Since the elderly have a degree of immune incomthe elderly subgroup. Overall, in terms of outcome, there is little evidence to suggest that one modality is petence and decreased hepatic enzyme activity (especially the P 450 enzyme system), they require less superior for the elderly ESRD patients [20] . At least in the long-term, technique survival appears to be aggressive immunotherapy.
Recent data from USRDS and from UNOS have greater in HD-treated patients. Two recent epidemiological studies from the US suggest that HD may be revealed that recipients of older kidneys (donor age 56-65 ) on average have lower graft survivals and lower associated with less mortality in the elderly diabetic (in the USRDS case-mix severity study, RR of death GFR's, without aÂecting patient survival [28] . These decrements in graft function are magnified at a donor was 1.25 for elderly diabetic on CAPD compared to HD) [21, 22] . All of the available studies comparing age above 60, and are reflected more in long-term survival (after 3 years) than in 1-year graft survival. elderly <70 years old (and possibly <75) free of recent or metastatic malignancy, active infection, severe The increased (but acceptable) risk of graft loss permit the conclusion that the donor pool should be expanded extrarenal disease (cardiac, pulmonary, hepatic) or mental or psychiatric illnesses should be considered to routinely include kidneys up to donor age of 60 years, that routine peri-harvest renal core biopsies for renal transplantation ( Figure 1) . (2 ) Expanding the donor pool to include older donors (56-65 ) is a should be used to evaluate the integrity of renal anatomy in donors between 60-65 years, and that suitable strategy if judiciously applied (excluding such kidneys when serum creatinine is >1.8-2.0 mg/dl ). older kidneys might be harvested for particular use in older recipients when 20-30 year graft survival are not Such older kidneys may be appropriately matched to older recipients. (3 ) Elderly patients should receive as important as in younger recipients. This age matching of donor and recipient is gaining support both as extensive information about ESRD therapy modalities.
They should be able to select the modality that maxima fair and a physiologically fair process [28, 29] . Further support for age matching comes from a recent izes their quality of life (including psychosocial adaptation). They should also be considered for rehabilitation report that kidneys from older donors survived for longer in older patients than in younger patients [30 ] . programs.
Finally, living-related transplantation may confer some benefit (compared to CRT ) in graft survival; its major limitation, however, remains the finding of a References suitable living donor [31] . . Under shear stress in the HD fistula, haemodialysis treatment. The preferred form is a prim-platelets are directly activated, adhere to the vessel ary arteriovenous fistula that has longest survival time wall, and release their constituents, which recruit other and a low complication rate. However, in some patients platelets and form aggregates which promote developthe vessels are unsuitable for primary arteriovenous ment of thrombosis. Glycoproteins GP Ib, GP IIb/IIIa fistula creation. Currently, the more common form of and extracellular Ca2+ are absolute necessities for this vascular access in such patients is polytetrafluoroethy-process. Intact endothelial cells exposed to a high shear lene (PTFE ) graft.
forces produce various vasodilatory, platelet inhibitory (NO, PGI 2 ) and fibrinolytic (t-PA) mediators that mitigate the activation of platelets and preserve blood Vascular access and haemostasis fluidity. However, when the endothelial cells ( EC ) are injured they are not able to oppose shear-stress-induced Thrombosis is a leading cause of any vascular access platelet aggregation, thus promoting platelet thrombus failure, and usually results from stenotic lesions caused formation. Needle puncture leading to endothelial damage may also play a role. by progressive neointimal hyperplasia in the venous An obstruction to venous outflow typically occurs Is there evidence for genetic predisposition?
within 5-6 cm of the arteriovenous anastomosis in a fistula and within 2-3 cm of the venous anastomosis Resistance to activated protein C (APC ) caused by a of the graft. It is more proximal in 15-20% of cases. single point mutation in the factor V gene (factor V Hypertrophied venous valves and sites of intimal Leiden) was recently identified as a thrombophilic trauma from old temporary catheters in central veins defect which is strongly associated with deep venous may lead to their stenoses and disturb outflow of blood thrombosis and recurrent idiopathic thromboembolfrom the distal access.
ism. However, a heterozygous carrier status for factor V Leiden does not appear to be a risk factor for vascular access thrombosis in haemodialysis
Can one identify the patient at high risk?
patients, possibly due to a high functional APC activity, which is very close to or within the normal range There is a higher risk of blood access failure in patients [6 ] . It cannot, however, be excluded that a homozygous with severe vascular endothelial injury, a useful marker factor V mutation represents an increased risk for of which is a high plasma thrombomodulin [3] . shunt thrombosis. Predisposing factors are diabetes mellitus, hypotension, hypoalbuminaemia, anticardiolipin antibodies, hyperThrombosis of vascular access-non-surgical homocysteinaemia, and increased serum levels of lipoprotein (a).
options
In a 2-year, cross-sectional, prospective pilot study in 30 non-diabetic haemodialysis patients with primary A treatment of access dysfunction requires a combined arteriovenous fistula in 11 (37%), a progressive stenosis medical, surgical, and radiologic approach. The primof the venous circuit, complicated by thrombosis in ary non-surgical therapy is angioplasty. Thrombolytic three of them was found [1 ] . Compared with 19 therapy may be tried as well. Valji et al.
[7] modified patients without fistula dysfunction, they had higher thrombolysis by a placement of two specially designed serum levels of monocyte chemoattractant protein-1 catheters with multiple side holes into the thrombus, ( MCP-1) and interleukin-6 (Il-6), two cytokines that oriented in opposite directions. Urokinase in a dose of regulate the proliferation of vascular smooth muscle 250 000-500 000 units is then injected in small pulses cells ( VSCM). In addition they had hyperinsulinaemia, as the catheters are advanced and withdrawn. A 98% hyperlipidaemia (high triglycerides and the ratio for success rate of that 'pulsed-spray pharmacomechanical cholesterol/HDL cholesterol ), and increased plasma thrombolysis' was reported. Newer techniques are levels of tissue plasminogen activator inhibitor (PAI-I) intravascular stents and directional atherectomy [8 ] . and factor VII.
The role of anticoagulants and platelet inhibitors Is there a role for serotonin and cytokines?
Anticoagulants and antiplatelet agents may be used in patients with recurrent graft thrombosis but always Serotonin (5HT ) released from dense granules of platelets may also stimulate thickening of the blood vessel after ruling out an anatomic cause for thrombosis. An attempt to identification of all contributing factors to wall in several ways. By amplifying the release of other aggregatory agents, 5HT facilitates ongoing platelet thrombosis including hypercoagulable state should be pursued. aggregation and thus the release of growth factors, in particular platelet-derived growth factor (PDGF).
There are no prospective, randomized studies to demonstrate a beneficial eÂect of vitamin K antagonists Even at low concentrations serotonin stimulates directly the mitogenesis of vascular smooth muscle cells in preventing graft thrombosis. Of many antiplatelet drugs acetylsalicylic acid (ASA) has been most studied. in culture. In vascular smooth muscle cells it significantly potentiates the mitogenesis induced by PDGF. It induces irreversible inactivation of platelet cyclooxygenase. Although, none of the trials achieved The 5HT 2 receptor antagonist, ketanserin, besides lowering the arterial blood pressure, exerts a significant acceptable statistical significance, most of the studies involving aspirin, alone or combined with dipyridamol, antiproliferative eÂects on vascular smooth muscle cells [4] . Growth of vascular smooth muscle cells is displayed trends toward prevention of fistula thrombosis [9] . Therefore if there are no contraindications also promoted by thrombin and angiotensin II.
In haemodialysis patients the increased concentra-ASA may be used for prevention of both threatened and recurrent fistula thrombosis. Enteric-coated ASA tion of IL-1 beta and TNF alpha may induce endothelial cells to increase prothrombotic activities including in a dose of 150-325 mg once a day after breakfast may be recommended. production of IL-6 and PAI-1, expression of intercellular adhesion molecule-1 ( ICAM-1) and vascular cell ASA does not inhibit ADP, thrombin, serotonin, and PAF-induced platelet aggregation. These mediadhesion molecule-1 ( VCAM-1) [5] . The enhanced circulating levels of VCAM-1 and ICAM-1 probably ators are generated and accumulate at sites of endothelial injury and vascular stenoses and they may be are the result of activation of endothelial cells and increased leukocyte/endothelial cells interactions.
responsible for reduction in blood flow in these
